# Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

> **NCT00792493** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 51 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ORM-12741

## Key facts

- **NCT ID:** NCT00792493
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2009-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00792493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00792493, "Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00792493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*